Tonight, the Senate passed a debt ceiling deal (HR 3746) by a 63-36 vote and it now heads to the President for his signature.
Earlier this evening, the Rhode Island Senate voted in unanimous support of Senate Bill S799. This legislation would ensure Rhode Islanders receive the total value of prescription drug assistance available to them, improving affordable access to care for many with prescription drug needs
President Joe Biden and U.S. House Speaker Kevin McCarthy announced a deal Saturday ahead of the looming debt ceiling deadline.
Rep. Susan Manchester reintroduced legislation that passed the House unanimously during the last session.
Leading patient groups representing millions of patients with chronic diseases and acute conditions are applauding the ruling today out of the U.S. Court of Appeals for the Fifth Circuit staying the U.S District Court’s remedy in Braidwood Management v. Becerra, a case which threatens coverage of U.S. Preventive Services Task Force (USPSTF) recommended preventive services without cost sharing as required under the Patient Protection and Affordable Care Act (ACA).
Chemotherapy drugs used to treat cancer are increasingly in short supply and have returned to the list of top-five drug classes affected by shortage.
Senator Mike Crapo was named a recipient of the “Fighting to End Cancer Award” during a virtual ceremony, Wednesday. The award was presented to Sen. Crapo on behalf of the American Cancer Society Cancer Action Network (ACS CAN) and several other cancer-fighting organizations in Idaho.
Today, patient groups representing millions of individuals with serious health conditions filed an amicus curiae (or friend-of-the-court) brief supporting the Department of Justice (DOJ)’s motion asking the U.S. Court of Appeals for the Fifth Circuit to stay the District Court’s judgment in the case of Braidwood v. Becerra.
Today, patient groups representing millions of individuals with serious health conditions filed an amicus curiae (or friend-of-the-court) brief supporting the Department of Justice (DOJ)’s motion asking the U.S. Court of Appeals for the Fifth Circuit to stay the District Court’s judgment in the case of Braidwood v. Becerra.
ACS CAN joined 32 patient and provider groups 33 organizations applauding the Supreme Court’s decision to pause new restrictions that would have limited access to the FDA-approved drug mifepristone while litigation about the drug works its way through the courts.